Tata Memorial Hospital Jobs for Government For Scientific Coordinator in Mumbai
Tata Memorial Hospital
Job Details : Post Name: Scientific Officer Pay Scale: Rs. 25000-30000/- Per Month Post Name: Scientific Coordinator Pay Scale: Rs.12000-15000/-Per Month Eligibility Criteria: Educational Qualification: For Scientific Officer: B.Sc (IT) Programming languages net framework. Frameworks : EJB, Struts2, Hibernet, JSF. For Scientific Coordinator: B.Sc & large scale population based studies. Nationality : Indian Age Limit : For Scientific Officer: 30 Years For Scientific Coordinator: 30 Years
B.Sc (IT) Programming languages net framework. Frameworks : EJB, Struts2, Hibernet, JSF. For Scientific Coordinator: B.Sc & large scale population based studies.
Looking for B.Sc graduates profile.
2015-09-11 to 2015-10-01
About Tata memorial hospital
The Tata Memorial Hospital was initially commissioned 57 years ago in 1941 with a small eighty bed Hospital. In 1952 the Indian Cancer Research Centre was established as a pioneer research institute for basic research - later called the Cancer Research Institute (CRI). In 1957 the Ministry of Health temporarily took over the Tata Memorial Hospital. The transfer of the administrative control of the Tata Memorial Centre (Tata Memorial Hospital and Cancer Research Institute) to the Department of Atomic Energy in 1962 was the next major milestone. This was due to the foresight and the vision of Dr. Homi Bhabha, who envisaged the major role that radiation would play in cancer treatment - from imaging to staging and actual therapy. The TMH and CRI merged as the two arms of the Tata Memorial Centre (TMC) in 1966 represented a classic example of private philanthropy augmented by Government support, with a mandate for Service, Education and Research in Cancer.
It is important to remember the contributions of Dr. J.C. Paymaster, Dr. E. Borges, Dr. D. Meher-Homji , Dr. D.J. Jussawalla, Dr. V.R. Khanolkar, Dr. K.J. Randive and many others towards building this Institute. In more recent times Dr. P.B. Desai, Dr. R.S. Rao, Dr. M.G. Deo, Dr. A.N. Bhisey and Dr. K.A. Dinshaw have given impetus to the rapid progress. With the total commitment of the DAE and successive Chairmen from Dr. H. Bhabha, Dr. V. Sarabhai, Dr. H.N. Sethna, Dr. R. Ramanna, Dr. M.R. Srinivasan, Dr. P.K. Iyengar and Dr. R.C. Chidambaram the Centre has rapidly expanded its functions and activities.
The current activities of the Tata Memorial Hospital and the level of eminence reached in its various spheres of expertise are worth recording. Nearly 25,000 patients visit the clinics annually not only from all over India but also from neighbouring countries. Nearly 60% of these cancer patients receive primary care at the Hospital of which over 70% are treated free of any charges. Over 1000 patients attend the OPD daily for medical advice, comprehensive care or for follow-up treatment. The Hospital has expanded from a 80 bed Hospital covering an area of 15,363 sq. meters to a 441-beds spread over 53,890 sq. meters. Our Annual Budget was Rs.5 lacs in 1941 - today it runs close to Rs.28 crores.
Nearly 15,000 minor operations, 8500 major operations and 500 laser surgeries are performed annually. About 5000 patients are treated with Radiotherapy and Chemotherapy annually in multi-disciplinary programs delivering well-established treatments.
Surgery remains the vital form of treatment along with radiation therapy and chemotherapy. Much progress has been made resulting in tremendous improvements in the overall survival of disease in many sites.
The strategies for early diagnosis, treatment management, rehabilitation, pain relief and terminal care have been established in a comprehensive and multidisiplinary approach for a total cancer care programme.
Many advances have taken place in every speciality. In surgery, the changing concepts have taken into account the biology of cancer. Radical surgeries have yielded place to more conservative surgery, with the very important objective of quality of life, conserving function and organ without compromising the overall survival outcomes. This has been very clearly proven in the early stage cancer of the breast or tumours involving the soft tissue or bone, where amputative surgery has been replaced by less radical procedures. Radiation therapy has also made rapid advances with high technology, precision, computerization and newer isotopes for therapy. Chemotherapy has played a very major role, with many new drugs and clinical protocols investigated in clinical trials.